Clinical trial
Efficacy and Safety of Initial Versus Delayed Verteporfin Photodynamic Therapy in Combination With Conbercept in Patients With Symptomatic Polypoidal Choroidal Vasculopathy
NCT02821520 is registered in ClinicalTrials.gov with The Eye Hospital of Wenzhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Initial Versus Delayed Verteporfin Photodynamic Therapy in Combination With Conbercept in Patients With Symptomatic Polypoidal Choroidal Vasculopathy
- Lead sponsor
- The Eye Hospital of Wenzhou Medical University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2017
- Completion date
- June 30, 2019
- Enrollment
- 80 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.